Clinical trial
Etoposide, Carboplatin, and Bleomycin in Treating Young Patients Undergoing…
NCT00276718 · Children's Cancer and Leukaemia Group, Other · Unknown status
Key facts
| NCT number | NCT00276718 |
|---|---|
| Title | Etoposide, Carboplatin, and Bleomycin in Treating Young Patients Undergoing Surgery For Malignant Germ Cell Tumors |
| Official title | Germ Cell Tumour Study II |
| Lead sponsor | Children's Cancer and Leukaemia Group, Other |
| Status | Unknown status |
| Study type | Interventional |
| Conditions | Brain and Central Nervous System Tumors, Childhood Germ Cell Tumor, Extragonadal Germ Cell Tumor, Ovarian Cancer |
| Intervention type | Biological, Drug, Procedure |
| Interventions | bleomycin sulfate, carboplatin, etoposide, conventional surgery |
| Enrollment | 100 |
| Start date | Apr 1, 1989 |
| First posted | Jan 13, 2006 |
| Last update posted | Sep 17, 2013 |
| Countries | Ireland, United Kingdom |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: